Roberto Cauda

20.8k total citations · 4 hit papers
330 papers, 12.2k citations indexed

About

Roberto Cauda is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Roberto Cauda has authored 330 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Infectious Diseases, 131 papers in Epidemiology and 106 papers in Virology. Recurrent topics in Roberto Cauda's work include HIV Research and Treatment (106 papers), HIV/AIDS drug development and treatment (78 papers) and HIV/AIDS Research and Interventions (61 papers). Roberto Cauda is often cited by papers focused on HIV Research and Treatment (106 papers), HIV/AIDS drug development and treatment (78 papers) and HIV/AIDS Research and Interventions (61 papers). Roberto Cauda collaborates with scholars based in Italy, United States and Japan. Roberto Cauda's co-authors include Mario Tumbarello, Antonio Cassone, Enrico Maria Trecarichi, Teresa Spanu, Evelina Tacconelli, Andrea Savarino, Giovanni Fadda, L Ortona, Andrea De Luca and Maurizio Sanguinetti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Roberto Cauda

318 papers receiving 11.8k citations

Hit Papers

Effects of chloroquine on... 1996 2026 2006 2016 2003 2012 2015 1996 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Roberto Cauda 5.5k 4.0k 2.7k 2.1k 1.5k 330 12.2k
Marilyn M. Wagener 8.6k 1.6× 8.0k 2.0× 1.9k 0.7× 1.2k 0.6× 1.3k 0.8× 171 17.1k
Shan‐Chwen Chang 7.9k 1.4× 6.6k 1.7× 4.2k 1.6× 614 0.3× 1.1k 0.7× 652 19.0k
Jan M. Prins 4.4k 0.8× 5.0k 1.3× 531 0.2× 2.6k 1.2× 1.5k 1.0× 402 11.6k
Robert A. Salata 3.7k 0.7× 2.5k 0.6× 1.4k 0.5× 1.1k 0.5× 544 0.4× 239 8.3k
A. Sarah Walker 4.9k 0.9× 2.8k 0.7× 1.7k 0.7× 876 0.4× 720 0.5× 264 10.5k
Myoung‐don Oh 6.1k 1.1× 3.1k 0.8× 1.7k 0.6× 349 0.2× 988 0.7× 337 11.7k
Mike Sharland 2.4k 0.4× 4.9k 1.2× 1.3k 0.5× 529 0.3× 3.1k 2.0× 367 11.5k
David R. Snydman 6.9k 1.2× 9.2k 2.3× 1.2k 0.5× 363 0.2× 897 0.6× 350 17.6k
Merle A. Sande 4.6k 0.8× 7.3k 1.8× 1.3k 0.5× 486 0.2× 1.0k 0.7× 234 13.9k
Pierluigi Viale 3.4k 0.6× 3.7k 0.9× 3.3k 1.2× 286 0.1× 1.7k 1.1× 419 10.1k

Countries citing papers authored by Roberto Cauda

Since Specialization
Citations

This map shows the geographic impact of Roberto Cauda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Cauda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Cauda more than expected).

Fields of papers citing papers by Roberto Cauda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Cauda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Cauda. The network helps show where Roberto Cauda may publish in the future.

Co-authorship network of co-authors of Roberto Cauda

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Cauda. A scholar is included among the top collaborators of Roberto Cauda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Cauda. Roberto Cauda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scarpa, Fabio, Francesco Branda, Giancarlo Ceccarelli, et al.. (2025). SARS-CoV-2 XEC: A Genome-Based Survey. Microorganisms. 13(2). 253–253. 3 indexed citations
2.
Scarpa, Fabio, Daria Sanna, Ilenia Azzena, et al.. (2023). Genome‐based comparison between the recombinant SARS‐CoV‐2 XBB and its parental lineages. Journal of Medical Virology. 95(3). e28625–e28625. 24 indexed citations
3.
Scarpa, Fabio, Ilenia Azzena, Marco Casu, et al.. (2023). Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5. Microorganisms. 11(4). 912–912. 9 indexed citations
4.
Donati, Katleen de Gaetano, Simona Costanzo, Lara Campana, et al.. (2022). Assessment of seasonal influenza vaccine effectiveness in patients from a central Italy reference hospital: pitfalls and intricacies from a pilot case-control study. SHILAP Revista de lepidopterología. 11(3).
5.
Scarpa, Fabio, Daria Sanna, Domenico Benvenuto, et al.. (2022). Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion. International Journal of Molecular Sciences. 23(23). 15264–15264. 20 indexed citations
6.
Pascarella, Stefano, Martina Bianchi, Marta Giovanetti, et al.. (2022). The Biological Properties of the SARS-CoV-2 Cameroon Variant Spike: An Intermediate between the Alpha and Delta Variants. Pathogens. 11(7). 814–814. 1 indexed citations
7.
Pascarella, Stefano, Massimo Ciccozzi, Davide Zella, et al.. (2021). SARS‐CoV‐2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?. Journal of Medical Virology. 93(12). 6551–6556. 74 indexed citations
8.
Lombardi, Francesca, Alberto Borghetti, Arturo Ciccullo, et al.. (2019). Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients. SHILAP Revista de lepidopterología. 20(3). 92–98. 11 indexed citations
9.
Tacconelli, Evelina, Maria Adriana Cataldo, Nico T. Mutters, et al.. (2019). Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections. International Journal of Antimicrobial Agents. 54(1). 49–54. 14 indexed citations
10.
Borghetti, Alberto, Davide Moschese, Antonella Cingolani, et al.. (2019). Lamivudine‐based maintenance antiretroviral therapies in patients living with HIV‐1 with suppressed HIV RNA: derivation of a predictive score for virological failure. HIV Medicine. 20(9). 624–627. 4 indexed citations
11.
Colafigli, Manuela, Arturo Ciccullo, Alberto Borghetti, et al.. (2019). Impact of Antiretroviral Therapy on the Risk of Recurrence in HIV-1 Infected Patients with Kaposi Sarcoma: A Multicenter Cohort Experience. Journal of Clinical Medicine. 8(12). 2062–2062. 5 indexed citations
12.
Murri, Rita, Marta Camici, Brunella Posteraro, et al.. (2018). Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients. SHILAP Revista de lepidopterología.
13.
Charlier, Caroline, Ingólfur Johannessen, Claire L. Mackintosh, et al.. (2017). International infectious diseases teaching to undergraduate medical students: A successful European collaborative experience.. PubMed. 39(9). 981–986.
14.
Tumbarello, Mario, Enrico Maria Trecarichi, Francesco Giuseppe De Rosa, et al.. (2015). Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study. Journal of Antimicrobial Chemotherapy. 70(7). 2133–2143. 395 indexed citations breakdown →
15.
Tacconelli, Evelina, Giulia De Angelis, Maria Adriana Cataldo, et al.. (2009). Antibiotic Usage and Risk of Colonization and Infection with Antibiotic-Resistant Bacteria: a Hospital Population-Based Study. Antimicrobial Agents and Chemotherapy. 53(10). 4264–4269. 114 indexed citations
16.
Puoti, Massimo, Bárbara Zanini, Andrea De Luca, et al.. (2008). 825 RESULTS OF A RANDOMIZED CONTROLLED TRIAL ON THE IMPACT OF PROLONGED COMBINATION ANTI-HCV TREATMENT IN HIV/HCV CO-INFECTED PATIENTS. Journal of Hepatology. 48. S309–S309. 1 indexed citations
17.
Tumbarello, Mario, Maurizio Sanguinetti, Eva Agostina Montuori, et al.. (2007). Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial Treatment. Antimicrobial Agents and Chemotherapy. 51(6). 1987–1994. 356 indexed citations
18.
Spanu, Teresa, Maurizio Sanguinetti, Mario Tumbarello, et al.. (2006). Evaluation of the New VITEK 2 Extended-Spectrum Beta-Lactamase (ESBL) Test for Rapid Detection of ESBL Production in Enterobacteriaceae Isolates. Journal of Clinical Microbiology. 44(9). 3257–3262. 66 indexed citations
19.
Rutella, Sergio, Carlo Rumi, Tiziano Barberi, et al.. (1999). Induction of CD69 antigen on normal CD4 and CD8 lymphocyte subsets and its relationship with the phenotype of responding T‐cells. Cytometry. 38(3). 95–101. 1 indexed citations
20.
Rutella, Sergio, et al.. (1998). Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness.. PubMed. 26(11). 1024–33. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026